abstract |
The present invention relates to compounds that are thyroid receptor ligands, and more particularly to antagonists, and to methods of using such compounds in the treatment of heart and metabolic diseases such as cardiac arrhythmias, thyrotoxicosis, asymptomatic hyperthyroidism, and liver disease. . |